Pancreatic autoantibodies and autoantibodies against goblet cells in pediatric patients with inflammatory bowel disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 55, Issue 4, 2012, Pages 429-435

  Kovacs, Marta ^a   Lakatos, Peter Laszlo ^b   Papp, Maria ^c   Jacobsen, Silvia ^d   Nemes, Eva ^c   Polgar, Marianne ^e   Solyom, Eniko ^f   Bodi, Piroska ^g   Horvath, Agnes ^h   Muller, Katalin Eszter ^b   Molnar, Kriszta ^b   Szabo, Doloresz ^b   Cseh, Aron ^b   Dezsofi, Antal ^b   Arato, Andras ^b   Veres, Gabor ^b  

^a Petz Aladar County and Teaching Hospital   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d Institute of Experimental Immunology   (Germany)

^e Madarász Children's Hospital   (Hungary)

^f University Teaching Hospital   (Hungary)

^g Pándy Kálmán Hospital   (Hungary)

^h Cholnoky Ferenc County Hospital   (Hungary)

Author keywords

GAB; Inflammatory bowel disease; PAB; Pediatric; rPAB

Indexed keywords

AUTOANTIBODY; CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENTERITIS; FEMALE; GOBLET CELL; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; ONSET AGE; PANCREAS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SACCHAROMYCES CEREVISIAE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, FUNGAL; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GOBLET CELLS; HUMANS; MALE; NEUTROPHILS; PANCREAS, EXOCRINE; SACCHAROMYCES CEREVISIAE; YOUNG ADULT;

SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 84866983025     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318256b516     Document Type: Article

References (37)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel diseases. Nature 2007;448:427-34. (Pubitemid 47123518)
2. Papp M, Altorjay I, Dotan N, et al. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behaviour, risk for surgery, and NOD2/CARD 15 genotype in a Hungarian IBD cohort. Am J Gastroenterol 2008; 103:665-81. (Pubitemid 351405992)
3. Stöcker W, Otte M, Ulrich S, et al. Autoimmunity to pancreatic juice in Crohn's disease. Results of autoantibody screening in patients with chronic inflammatory bowel disease. Scand J Gastroenterol Suppl 1987;22:41-52.
4. Lakatos PL, Altorjay I, Szamosi T, et al. Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behaviour, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort. Inflamm Bowel Dis 2009;15:365-74.
5. Joossens S, Vermeire S, Van Steen K, et al. Pancreatic autoantibodies in inflammatory bowel disease. Inflamm Bowel Dis 2004;10:771-7. (Pubitemid 39545223)
6. Roggenbuck D, Hausdorf G, Martinez-Gamboa L, et al. Identification of GP2, the major zymogen granule membrane glycoprotein, as autoantigen of pancreatic antibodies in Crohn's disease. Gut 2009;58:1620-8.
7. Roggenbuck D, Reinhold P, Wex T, et al. Autoantibodies to GP2, the major zymogen granule membran glycoprotein, are new markers in Crohn's disease. Clin Chim Acta 2011;412:718-24.
8. Bogdanos DP, Rigopoulou EI, Smyk DS, et al. Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies. Autoimmun Rev 2011;11:143-8.
9. Klebl FH, Bataille F, Huy C, et al. Association of antibodies to exocrine pancreas with subtypes of Crohn's disease. Eur J Gastroenterol Hepatol 2005;17:73-7. (Pubitemid 40128930)
10. Hibi T, Ohara M, Kobayashi K, et al. Enzyme linked immunosorbent assay (ELISA) and immunoprecipitation studies on anti-goblet cell antibody using a mucin producing cell line in patients with inflammatory bowel disease. Gut 1994;35:224-30. (Pubitemid 24092869)
11. Lawrance IC, Hall A, Leong R, et al. A comparative study of globlet cell and pancreatic exocrine autoantibodies combined with ASCA and pANCA in Chinese and Caucasian patients with IBD. Inflamm Bowel Dis 2005;11:890-7. (Pubitemid 41428847)
12. Dubinsky MC, Ofman JJ, Urman M, et al. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol 2001;96:758-65. (Pubitemid 32240727)
13. Zholudev A, Zurakowski D, Young W, et al. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol 2004;99:2235-41. (Pubitemid 39524716)
14. Khan K, Schwarzenberg SJ, Sharp H, et al. Role of serology and routine laboratory tests in childhood inflammatory bowel disease. Inflamm Bowel Dis 2002;8:325-9.
15. Dubinsky MC, Kugathasan S, Mei L, et al. Increased immune reactivity predicts aggressive complicating Crohn's disease in children. Clin Gastroenterol Hepatol 2008;10:1105-11.
16. Amre DK, Lu SE, Costea F, et al. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients. Am J Gastroenterol 2006;101:645-52. (Pubitemid 43340944)
17. Vasiliauskas EA, Kam LY, Karp LC, et al. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 2000;47:487-96.
18. Dubinky M. Special issues in pediatric inflammatory bowel disease. World J Gastroenterol 2008;14:413-20.
19. Ruemmele FM, Targan SR, Levy G, et al. Diagnostic accuracy of serological assay in pediatric inflammatory bowel disease. Gastroenterology 1998;115:822-9. (Pubitemid 28452928)
20. Kundhal PS, Critch JN, Zachos M, et al. Paediatric Crohn disease activity index: response to short-term change. J Pediatr Gastroenterol Nutr 2003;36:83-9. (Pubitemid 41672624)
21. Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a paediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 2007;133:423-32. (Pubitemid 47193130)
22. Heliö T, Halme L, Lappalainen M, et al. CARD15/NOD2 gene variants are associated with family occuring and complicated forms of Crohn's disease. Gut 2003;52:558-62. (Pubitemid 36363411)
23. Desplat-Jego S, Johanet C, Escande A, et al. Update on anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated antineutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunfluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study. World J Gastroenterol 2007;13:2312-8. (Pubitemid 46860731)
24. Holzl MA, Hofer J, Kavarik JJ, et al. The zymogen granule protein 2 (GP2) binds to scavanger receptor expressed on endothelial cells1 (SREC-1). Cell Immunol 2011;267:88-93.
25. Ohno H, Hase K. Glycoprotein 2 (GP2): grabbing the FimH bacteria into M cells for mucosal immunity. Gut Microbes 2010;1:401-7.
26. Koutroubakis IE, Drygiannakis D, Karmiris K, et al. Pancreatic autoantibodies in Greek patients with inflammatory bowel disease. Dig Dis Sci 2005;50:2330-4. (Pubitemid 43106388)
27. Markowitz J, Kugathasan S, Dubinsky M, et al. Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology? Inflamm Bowel Dis 2009;15:714-9.
28. Dubinky MC, Lin YC, Dutridge D, et al. Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression. Am J Gastroenterol 2006;101:360-7. (Pubitemid 43381681)
29. Elitsur Y, Lawrence Z, Tolaymat N. The diagnostic accuracy of serologic markers in children with IBD: the West Virginia experience. J Clin Gastroenterol 2005;39:670-3. (Pubitemid 41177084)
30. Muratori P, Muratori L, Guidi M, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol 2003;132:473-6. (Pubitemid 36713954)
31. Demirsoy H, Ozdil K, Ersoy O, et al. Anti-pancreatic antibody in Turkish patients with inflammatory bowel disease and first-degree relatives. World J Gastroenterol 2010;16:5732-8.
32. Bartunkova J, Kolárová I, Sedivá A, et al. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel disease. Clin Immunol 2002;102:62-8.
33. Arnott ID, Landers CJ, Nimmo EJ, et al. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol 2004;99:2376-84. (Pubitemid 40039369)
34. Papp M, Altorjay I, Norman GL, et al. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behaviour and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Inflamm Bowel Dis 2007;13:984-92. (Pubitemid 47309970)
35. Kugathasan S, Collins N, Maresso K, et al. CARD15 gene mutations and risk for early surgery in pediatric-onset Crohn's disease. Clin Gastroenterol Hepatol 2004;2:1003-9. (Pubitemid 39539750)
36. Adler J, Rangwalla SC, Dwamena BA, et al. The prognostic power of the NOD2 genotype for complicated Crohn's disease: a meta-analysis. Am J Gastroenterol 2011;106:699-712.
37. Roesler J, Thüringen A, Sun L, et al. Influence of CARD15 mutations on disease activity and responses to therapy in 65 pediatric Crohn patients from Saxony, Germany. J Pediatr Gastroenterol Nutr 2005;41:27-32. (Pubitemid 40967351)